Medi-Caps EBIT per Share
The EBIT per Share of Medi-Caps (523144.BO) as of Oct 9, 2026 is -8.98 INR. In the previous year, EBIT per Share was -0.65 INR — a change of 1,271.40% (lower).
Get this data via API
Financial Data API
EBIT per Share
-8.98INR
YoY
1,271.40%
Last updated:
EBIT per Share of Medi-Caps is 2026 -8.98 INR. EBIT per Share of Medi-Caps was 2025 -0.65 INR. It decreases by 1,271.40% lower compared to the previous year.
The Medi-Caps EBIT per Share history
3 Years
10 Years
25 Years
Max
EBIT per Share
Date
EBIT per Share
Jan 1, 2019
2.24 INR
Jan 1, 2020
-6.97 INR
Jan 1, 2021
7.50 INR
Jan 1, 2022
6.53 INR
Jan 1, 2023
3.95 INR
Jan 1, 2024
-1.38 INR
Jan 1, 2025
-0.65 INR
Jan 1, 2026
-8.98 INR
| YEAR | EBIT per Share | YoY |
|---|---|---|
| -8.98INR | +1,271.40% | |
| -0.65INR | -52.57% | |
| -1.38INR | -134.96% | |
| 3.95INR | -39.56% | |
| 6.53INR | -12.93% | |
| 7.50INR | -207.66% | |
| -6.97INR | -411.40% | |
| 2.24INR | +888.65% | |
| 0.23INR | -200.30% | |
| -0.23INR | -136.54% | |
| 0.62INR | -151.19% | |
| -1.21INR | -183.25% | |
| 1.45INR | +24.91% | |
| 1.16INR | -36.40% | |
| 1.82INR | -45.06% | |
| 3.32INR | +51.46% | |
| 2.19INR | -22.38% | |
| 2.82INR | +21.31% | |
| 2.33INR | -10.74% | |
| 2.61INR | — |
Access this data via the Eulerpool API
Medi-Caps Stock analysis
What does Medi-Caps do? Medi-Caps is one of the most popular companies on Eulerpool.
Frequently Asked Questions about Medi-Caps stock
EBIT per Share of Medi-Caps is -8.98 INR in 2026.
EBIT per Share of Medi-Caps changed from -0.65 INR to -8.98 INR, representing a 1,271.40% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of EBIT per Share Medi-Caps since 2006 – with annual values, charts, and detailed analysis.
EBIT per Share measures operating profit allocated to each outstanding share.
Access this data via the Eulerpool API
Income Statement — Medi-Caps
All Key Metrics — Medi-Caps
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth